What are investors reading? Last week the Greek elections dominated the news, but many of you were more concerned with the hunt for yield. Here are the top 10 articles and videos from Morningstar.co.uk, as chosen by fellow Morningstar.co.uk readers over the past week.
Top 20 FTSE 350 Dividend Paying Stocks
UPDATED JANUARY 2015: A well-blended portfolio of stocks from the FTSE 350 can provide investors with a diversified sustainable income for life
Lloyds to Pay 4% Dividend
We see Lloyds as the most attractive play on the U.K. banking market because of its positioning, improving financial results, and attractive valuation
How to Maximise Your Retirement Income
An alarming number of baby-boomers are failing to save for retirement - and too many are relying on cash to deliver growth. So what can be done to maximise your pension?
3 Trusts to Consider in 2015
ASK THE EXPERT: These closed-end funds are highly rated by analysts but have underperformed expectations in recent years, could 2015 be the year they rebound?
Fund Basics
A guide to fund investing for beginners...and those more experienced investors who need a re-cap
Investors Sell £6bn Invesco Income Funds for Woodford and M&G
Last year investors sold up their holdings in Invesco Perpetual's equity income funds to the tune of £6 billion - but it wasn't just Woodford Funds who benefitted from the cash
3 Steady Eddie Europe Stocks
With the European Central Bank taking action to prop up the eurozone economies, stable European listed stocks with an economic moat may be an attractive bet
3 Five Star Undervalued Stocks
THE VALUE INVESTOR: These three UK companies are trading at significantly less than their fair value
Investment Trusts Market Update
Last year investment trusts across the sectors moved to simplify and reduce fees - and the trend continues in 2015. Also this month, British Asset's radical mandate change
Greek Election: What the Experts Say
What does the election of Greece's leftist Syriza party mean for the Greek economy – and the wider impact on the Eurozone? We asked professional investors and market makers